NAD+ levels decline by 40–60% between young adulthood and old age, impairing sirtuin activity, mitochondrial function, and DNA repair — but whether NAD+ precursor supplementation reverses these effects in humans remains under investigation.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for energy metabolism, DNA repair, and the activity of sirtuins (longevity-associated deacetylases). NAD+ levels decline by 40–60% between young adulthood and old age, impairing mitochondrial function and DNA repair capacity. NMN and NR (NAD+ precursors) raise NAD+ levels in humans, but whether this translates to meaningful health or longevity benefits remains under investigation.
Yoshino et al. (2011) demonstrated that NAD+ levels decline with age in mice and that NMN supplementation restores NAD+ levels and improves metabolic function. Verdin (2015) in Science reviewed the evidence for NAD+ in aging, concluding that NAD+ decline is a driver of mitochondrial dysfunction and age-related metabolic disease. A 2021 RCT by Yoshino et al. in Science randomised 25 postmenopausal women with prediabetes to NMN (250mg/day) or placebo for 10 weeks. NMN significantly increased skeletal muscle NAD+ levels and improved insulin sensitivity and muscle insulin signalling, but did not affect body composition or physical function.
"NMN supplementation raised skeletal muscle NAD+ levels and improved insulin sensitivity in postmenopausal women with prediabetes."
— Yoshino et al., Science 2021
The NIA is funding research into NAD+ metabolism and its role in aging, noting that NAD+ precursors are among the most promising candidates for longevity interventions. The NIA cautions that while animal data are compelling, human evidence for NMN and NR remains limited to short-term studies with surrogate endpoints. Neither the FDA nor any major health authority has approved NMN or NR for longevity or anti-aging use.
NMN and NR supplements are widely available and generally considered safe at standard doses (250–500mg/day). The human evidence base is growing but remains limited to short-term studies with metabolic endpoints. The most evidence-supported ways to maintain NAD+ levels are: regular aerobic exercise (which upregulates NAD+ biosynthesis); avoiding excess alcohol (which depletes NAD+); maintaining a healthy weight; and adequate dietary niacin (vitamin B3, the primary dietary NAD+ precursor). Whether NMN or NR supplementation provides benefits beyond these lifestyle approaches in healthy adults is not yet established.
Vitaei verdict
NAD+ decline is a real and well-characterised feature of aging with mechanistic links to mitochondrial dysfunction. NMN/NR supplements raise NAD+ levels in humans, but whether this translates to meaningful longevity benefits remains to be established in longer-term RCTs.
What Are the Hallmarks of Aging? A Comprehensive Review of the Biological Processes Driving Senescence
Aging is a complex biological process characterised by a progressive decline in physiological function and increased vulnerability to disease. This article elucidates the nine interconnected hallmarks of aging, as established by robust scientific consensus, detailing their cellular and molecular underpinnings and the evidence supporting their role in the aging phenotype.
What Is the Evidence for Metformin as a Longevity Drug?
Metformin activates AMPK and inhibits mTOR — the same pathways engaged by caloric restriction — and observational data suggest diabetic patients on metformin outlive matched non-diabetic controls, but RCT longevity evidence in non-diabetics is pending.
How Does Caloric Restriction Extend Lifespan and What Is the Human Evidence?
Caloric restriction extends lifespan in virtually every organism studied, from yeast to primates, through activation of AMPK, inhibition of mTOR, and sirtuins — but human evidence remains limited to biomarker improvements rather than direct longevity data.